Trader worries have led to a selloff in health care product makers, sending iShares US Medical Products Trade-traded fund down seven per cent this yr. Fund supervisors might still be concerned about investing in stocks perceived to become One of the “GLP-1 losers,” stated HSBC analyst Rajesh Kumar.We don't boost products we don't personal or wo